Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy

Triple-negative breast cancers are often characterized by aggressive behavior and short clinical course once they become chemotherapy-resistant. We describe below a patient who has shown a response to combination of chemotherapy with Elenagen, a plasmid encoding p62. Elenagen was tested in a previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponomarenko, Dmitry M., Gabai, Vladimir L., Sufianov, Albert A., Kolesnikov, Sergey I., Shneider, Alexander M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980632/
https://www.ncbi.nlm.nih.gov/pubmed/32076489
http://dx.doi.org/10.18632/oncotarget.27323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980632/
https://www.ncbi.nlm.nih.gov/pubmed/32076489
http://dx.doi.org/10.18632/oncotarget.27323

Ejemplares similares